These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37200519)

  • 21. Will the nation be ready for the next bioterrorism attack? Mending gaps in the public health infrastructure.
    Salinsky E
    NHPF Issue Brief; 2002 Jun; (776):1-19. PubMed ID: 12083160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical Countermeasures: A Stitch in Time Saves Nine.
    Kim-Farley RJ
    Am J Public Health; 2018 Sep; 108(S3):S177-S178. PubMed ID: 30192660
    [No Abstract]   [Full Text] [Related]  

  • 23. Taking the measure of countermeasures: leaders' views on the nation's capacity to develop biodefense countermeasures.
    Gilfillan L; Smith BT; Inglesby TV; Kodukula K; Schuler A; Lister M; O'Toole T
    Biosecur Bioterror; 2004; 2(4):320-7. PubMed ID: 15650441
    [No Abstract]   [Full Text] [Related]  

  • 24. E3LSI research: an essential element of biodefense.
    Green SK
    Biosecur Bioterror; 2005; 3(2):128-37. PubMed ID: 16000044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodefense and public health preparedness in Virginia.
    Porse CC
    Biosecur Bioterror; 2009 Mar; 7(1):73-84. PubMed ID: 19379106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regionalization of bioterrorism preparedness and response.
    Bravata DM; McDonald KM; Owens DK; Wilhelm ER; Brandeau ML; Zaric GS; Holty JE; Liu H; Sundaram V
    Evid Rep Technol Assess (Summ); 2004 Apr; (96):1-7. PubMed ID: 15133889
    [No Abstract]   [Full Text] [Related]  

  • 27. Experiential Adult Learning: A Pathway to Enhancing Medical Countermeasures Capabilities.
    Arora M; Granillo B; Zepeda TK; Burgess JL
    Am J Public Health; 2018 Nov; 108(S5):S378-S380. PubMed ID: 30422695
    [No Abstract]   [Full Text] [Related]  

  • 28. A simulation-based biodefense and disaster preparedness curriculum for internal medicine residents.
    Summerhill EM; Mathew MC; Stipho S; Artenstein AW; Jagminas L; Russo-Magno PM; Potter S; Shapiro MJ
    Med Teach; 2008; 30(6):e145-51. PubMed ID: 18608964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?
    De Groot AS; Einck L; Moise L; Chambers M; Ballantyne J; Malone RW; Ardito M; Martin W
    Hum Vaccin Immunother; 2013 Sep; 9(9):1877-84. PubMed ID: 23877094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost/success projections for US biodefense countermeasure development.
    Matheny J; Mair M; Smith B
    Nat Biotechnol; 2008 Sep; 26(9):981-3. PubMed ID: 18779804
    [No Abstract]   [Full Text] [Related]  

  • 31. Interdependent Factors of Demand-Side Rationale for Chemical, Biological, Radiological, and Nuclear Medical Countermeasures.
    Johnson ML; Belin J; Dorandeu F; Guille M
    Disaster Med Public Health Prep; 2020 Dec; 14(6):739-755. PubMed ID: 31735188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing nursing research opportunities in biodefense: National Institute of Nursing Research Science workgroup.
    Sigmon HD; Larson EL
    Biol Res Nurs; 2003 Apr; 4(4):306-10. PubMed ID: 12698923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current State of Mass Vaccination Preparedness and Operational Challenges in the United States, 2018-2019.
    Hosangadi D; Shearer MP; Warmbrod KL; Kan L; Cantu M; Nuzzo JB
    Health Secur; 2020 Dec; 18(6):473-482. PubMed ID: 33017195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges and Strategies in the Development of Radiation Biodosimetry Tests for Patient Management.
    Satyamitra M; Reyes Turcu FE; Pantoja-Galicia N; Wathen L
    Radiat Res; 2021 Nov; 196(5):455-467. PubMed ID: 34143223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Confronting current and future medical threats through new organization, policies, and countermeasures--a French perspective.
    Lafont B
    Mil Med; 2008 Apr; 173(4):xii-xv. PubMed ID: 18472619
    [No Abstract]   [Full Text] [Related]  

  • 36. Planning Considerations for State, Local, Tribal, and Territorial Partners to Receive Medical Countermeasures From CDC's Strategic National Stockpile During a Public Health Emergency.
    Bhavsar TR; Esbitt DL; Yu PA; Yu Y; Gorman SE
    Am J Public Health; 2018 Sep; 108(S3):S183-S187. PubMed ID: 30192668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The strategic plan for preparedness and response to bioterrorism in Korea].
    Hwang HS
    J Prev Med Public Health; 2008 Jul; 41(4):209-13. PubMed ID: 18664725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. A decade in biosecurity. Introduction.
    Inglesby TV; Henderson DA
    Biosecur Bioterror; 2012 Mar; 10(1):5. PubMed ID: 22455674
    [No Abstract]   [Full Text] [Related]  

  • 39. Biodefense countermeasures: the impact of Title IV of the US Pandemic and All-Hazards Preparedness Act.
    Gronvall G
    Emerg Health Threats J; 2008; 1():e3. PubMed ID: 22460212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. State-of-the-art therapeutic medical countermeasures for viral threat agents.
    Sampath A; Metz M; Stundick M; Larsen JC
    Biosecur Bioterror; 2011 Dec; 9(4):351-60. PubMed ID: 22053938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.